Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.

F. Passiglia, S. Pilotto, F. Facchinetti, L. Bertolaccini, M. Del Re, R. Ferrara, T. Franchina, U. Malapelle, J. Menis, A. Passaro, S. Ramella, G. Rossi, R. Trisolini, S. Novello

Research output: Contribution to journalArticlepeer-review

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Original languageEnglish
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - Feb 1 2020

Fingerprint Dive into the research topics of 'Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.'. Together they form a unique fingerprint.

Cite this